BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 26497244)

  • 21. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
    Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation.
    Guo F; Li J; Qi Y; Hou J; Chen H; Jiang SW
    Cancer Cell Int; 2020; 20():163. PubMed ID: 32435154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines.
    Lu Q; Chen H; Senkowski C; Wang J; Wang X; Brower S; Glasgow W; Byck D; Jiang SW; Li J
    Oncol Rep; 2016 Jan; 35(1):163-70. PubMed ID: 26497244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
    Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
    Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.
    Qu W; Li J; Duan P; Tang Z; Guo F; Chen H; Zhu X; Jiang SW
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1271-1282. PubMed ID: 27784171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review.
    Mais V; Fais ML; Peiretti M; Fanni D; Massa E; Carboni G; Fais G; Deo G; Angioni S
    Curr Oncol; 2022 Nov; 29(11):8540-8555. PubMed ID: 36354733
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.